Is abaloparatide more efficacious on increasing bone mineral density than teriparatide for women with postmenopausal osteoporosis? An updated meta-analysis
Abstract Purpose Osteoporosis poses a challenge to public health, causing fragility fractures, especially in postmenopausal women.Abaloparatide Holders (ABL) is an effective anabolic agent to improve bone formation and resorption among postmenopausal women with osteoporosis.Our meta-analysis aims to assess the effectiveness and safety of ABL versus